AIMS/HYPOTHESIS: The study aimed to assess, in multiple populations, the role of HLA alleles on early and late age at onset of type 1 diabetes. METHODS: Stepwise linear regression models were used to determine which HLA class I and class II risk alleles to include. High-resolution genotyping data for patients from the Type 1 Diabetes Genetics Consortium (T1DGC) collection (n = 2,278) and four independent cohorts from Denmark, Sardinia and the USA (Human Biological Data Interchange [HBDI] and Joslin Diabetes Center) (n = 1,324) (total n = 3,602) were used to assess the role of HLA variation on age of onset and predict early onset (age ≤ 5 years) and late onset (age ≥ 15 years) of type 1 diabetes. RESULTS: In addition to carriage of HLA class I alleles A*24:02, B*39:06, B*44:03 and B*18:01, HLA class II DRB1-DQB1 loci significantly contributed to age at onset, explaining 3.4% of its variance in the combined data. HLA genotypes, together with sex, were able to predict late onset in all cohorts studied, with AUC values ranging from 0.58 to 0.63. Similar AUC values (0.59-0.70) were obtained for early onset for most cohorts, except in the Sardinian study, in which none of the models tested had significant predictive power. CONCLUSIONS/ INTERPRETATION: HLA associations with age of onset are consistent across most white populations and HLA information can predict some of the risk of early and late onset of type 1 diabetes. Considerable heterogeneity was observed between Sardinian and other populations, particularly with regard to early age of onset.
AIMS/HYPOTHESIS: The study aimed to assess, in multiple populations, the role of HLA alleles on early and late age at onset of type 1 diabetes. METHODS: Stepwise linear regression models were used to determine which HLA class I and class II risk alleles to include. High-resolution genotyping data for patients from the Type 1 Diabetes Genetics Consortium (T1DGC) collection (n = 2,278) and four independent cohorts from Denmark, Sardinia and the USA (Human Biological Data Interchange [HBDI] and Joslin Diabetes Center) (n = 1,324) (total n = 3,602) were used to assess the role of HLA variation on age of onset and predict early onset (age ≤ 5 years) and late onset (age ≥ 15 years) of type 1 diabetes. RESULTS: In addition to carriage of HLA class I alleles A*24:02, B*39:06, B*44:03 and B*18:01, HLA class II DRB1-DQB1 loci significantly contributed to age at onset, explaining 3.4% of its variance in the combined data. HLA genotypes, together with sex, were able to predict late onset in all cohorts studied, with AUC values ranging from 0.58 to 0.63. Similar AUC values (0.59-0.70) were obtained for early onset for most cohorts, except in the Sardinian study, in which none of the models tested had significant predictive power. CONCLUSIONS/ INTERPRETATION: HLA associations with age of onset are consistent across most white populations and HLA information can predict some of the risk of early and late onset of type 1 diabetes. Considerable heterogeneity was observed between Sardinian and other populations, particularly with regard to early age of onset.
Authors: B P Koeleman; M H Herr; P Zavattari; F Dudbridge; R March; D Campbell; A H Barnett; S C Bain; A P Mulargia; M Loddo; W Amos; F Cucca; J A Todd Journal: Ann Hum Genet Date: 2000-05 Impact factor: 1.670
Authors: Theresa A Aly; Akane Ide; Mohamed M Jahromi; Jennifer M Barker; Maria S Fernando; Sunanda R Babu; Liping Yu; Dongmei Miao; Henry A Erlich; Pamela R Fain; Katherine J Barriga; Jill M Norris; Marian J Rewers; George S Eisenbarth Journal: Proc Natl Acad Sci U S A Date: 2006-09-11 Impact factor: 11.205
Authors: Theresa A Aly; Akane Ide; Kurt Humphrey; Jennifer M Barker; Andrea Steck; Henry A Erlich; Liping Yu; Dongmei Miao; Maria J Redondo; Kim McFann; Christine M Roberts; Sunanda R Babu; Jill M Norris; George S Eisenbarth; Marian J Rewers Journal: J Autoimmun Date: 2005-10-19 Impact factor: 7.094
Authors: Kustaa Hietala; Valma Harjutsalo; Carol Forsblom; Paula Summanen; Per-Henrik Groop Journal: Diabetes Care Date: 2010-02-25 Impact factor: 19.112
Authors: Henry Erlich; Ana Maria Valdes; Janelle Noble; Joyce A Carlson; Mike Varney; Pat Concannon; Josyf C Mychaleckyj; John A Todd; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Priscilla Moonsamy Journal: Diabetes Date: 2008-02-05 Impact factor: 9.461
Authors: H P V Silva; M A G Ururahy; K S C Souza; M B Loureiro; Y M C Oliveira; G H M Oliveira; A D Luchessi; K T C Carvalho; J C O C Freitas; E A Donadi; R D C Hirata; M G Almeida; R F Arrais; M H Hirata; A A Rezende Journal: Genes Immun Date: 2015-10-22 Impact factor: 2.676
Authors: Jamie R J Inshaw; Antony J Cutler; Daniel J M Crouch; Linda S Wicker; John A Todd Journal: Diabetes Care Date: 2019-09-26 Impact factor: 19.112
Authors: Anette-Gabriele Ziegler; Peter Achenbach; Reinhard Berner; Kristina Casteels; Thomas Danne; Melanie Gündert; Joerg Hasford; Verena Sophia Hoffmann; Olga Kordonouri; Karin Lange; Helena Elding Larsson; Markus Lundgren; Matthew D Snape; Agnieszka Szypowska; John A Todd; Ezio Bonifacio Journal: BMJ Open Date: 2019-06-28 Impact factor: 2.692
Authors: Anna E Long; Kathleen M Gillespie; Rachel J Aitken; Julia C Goode; Polly J Bingley; Alistair J K Williams Journal: Diabetes Date: 2013-02-08 Impact factor: 9.461
Authors: J A Traherne; W Jiang; A M Valdes; J A Hollenbach; J Jayaraman; J A Lane; C Johnson; J Trowsdale; J A Noble Journal: Genes Immun Date: 2015-10-22 Impact factor: 2.676
Authors: Daniel J Perry; Clive H Wasserfall; Richard A Oram; MacKenzie D Williams; Amanda Posgai; Andrew B Muir; Michael J Haller; Desmond A Schatz; Mark A Wallet; Clayton E Mathews; Mark A Atkinson; Todd M Brusko Journal: Sci Rep Date: 2018-03-14 Impact factor: 4.379